Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 7, Issue 7 (2018)

The effect of combined pharmacotherapy on the dynamics of cardiog hemodynamics and cardiac pacing variability in patients with arterial hypertension

Author(s):
Gryniv OI
Abstract:
Dynamic observation and treatment of 145 patients with stage II arterial hypertension has been performed. Approbation therapy included a comparison of the effectiveness of the use of basic antihypertensive therapy, an additional use of the drug magnesium or mebiker or their simultaneous administration. It is proved that the use of magnesium medication contributes to a significant decrease in the daily average systolic and diastolic blood pressure. An additional appointment of the mebiker coincides with the sympathetic and parasympathetic links of the autonomic nervous system. Consequently, the appointment of proven pharmacological agents has pathogenetic justification and is appropriate in patients with arterial hypertension stage II.
Pages: 507-511  |  137 Views  11 Downloads
How to cite this article:
Gryniv OI. The effect of combined pharmacotherapy on the dynamics of cardiog hemodynamics and cardiac pacing variability in patients with arterial hypertension. Pharma Innovation 2018;7(7):507-511.
The Pharma Innovation Journal